Delivery Order SPE2DB22D3009-SPE2DB24FAP24
Award Date 2/5/24
Potential Completion Date 2/6/24
Potential Value $2.8K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide Amlodipine-Valsartan 5-160 mg 30s medication. The $12,960.31 contract has a performance period through March 7, 2024 and does not have a set-aside designation. AmerisourceBergen Drug Corp is also the prime contractor on a larger $999,999,999.00 indefinite delivery contract (IDC) awarded by DLA, which serves as the...
- This is a $1,161.72 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of AMLODIPINE-VALSARTAN 10-160 MG 30S medication. The contract has a completion date of June 6, 2025 and is not set aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00, which allows the company to supply a wide range of pharmaceutical...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,161.72, is for the delivery of AMLODIPINE-VALSARTAN 10-160 MG 30S, a cardiovascular medication. This is a delivery order contract with a firm fixed price pricing type, with a completion date of March 12, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, in the amount of $3,131.74 for the supply of 90 tablets of the medication Valsartan-HCTZ 320-25 mg. The contract, which does not have a set-aside designation, has a completion date of March 4, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is issued under an indefinite delivery contract with DLA...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,259.86, is for the delivery of 4567330158 AMLODIPINE-VALSARTAN 5-160 MG 30S, a cardiovascular medication. The contract is a Firm Fixed Price Delivery Order with a performance period running through February 2025. The award is not designated as a set-aside contract. AmerisourceBergen holds a...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office Division. The $6,335.22 firm-fixed-price contract is for the supply of the pharmaceutical product Amlodipine-Valsartan 5-160 mg in 30-count packages. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive...
- This is a delivery order contract awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $4,222.26 firm fixed-price contract is to provide 4567741879 ! AMLODIPINE-VALSARTAN 5-160 MG 30S, a cardiovascular medication, to support military healthcare programs. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which...
- This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,551.21 firm fixed-price delivery order is for the supply of AMLOD-VALSA-HCTZ 10-160-25 MG 30S, a pharmaceutical product. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The $25,916.08 contract is for the delivery of Valsartan-HCTZ 320-25 mg tablets in 90-count packages. This delivery order is part of a larger $999,999,999.00 indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, which serves as the...
- The Defense Logistics Agency awarded a delivery order valued at $1,249.38 to AmerisourceBergen Drug Corp for the supply of Amlodipine-Valsartan 10-160 mg tablets (30-count package). The contract, awarded January 6, 2026, with an ultimate completion date of January 7, 2026, utilizes firm fixed-price pricing with no set-aside designation, indicating competitive award to this vendor. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will...
- SPE2DB22D3009Indefinite Delivery Contract
- SPE2DB22D3009-SPE2DB24FAP24Delivery Order
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a for-profit global pharmaceutical distribution company. The $2,837.70 contract is to provide AMLODIPINE-VALSARTAN 5-160 MG 30S medication to support military treatment programs and facilities. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen Drug Corp holds with DLA to deliver a comprehensive range of pharmaceutical products and medical supplies through December 31, 2025. No set-aside designation was used for this specific award.
Generated 5/6/24, 9:12 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.8k | 2/5/24 |